New Efficient Reagent For Stem Cell Transfection


DreamFect™ Stem transfection reagent from Oz Biosciences is specifically developed for transfection of Stem Cell

Marseille (I-Newswire) February 21, 2013 - OZ Biosciences SAS, specialized in the development of innovative transfection technologies is delighted to announce the launching of his new product DreamFect™ Stem.

Stem cells are widely investigated due to their regenerative potential. In many cases, it would prove useful to enhance or silence some of their features through gene delivery strategies to harness their full potential cell/gene-based therapy. Because stem cells behavior, physiology and properties are quite distinctive to other cells, OZ Biosciences has developed a specific transfection reagent for stem cells.
DreamFect™ Stem exhibits high transfection efficiency on human adult multipotent stem cells such as MSC (Mesenchymal Stem Cells), AdSC (Adipose derived Stem Cells), AFSC (Amniotic Fluid Stem Cells), and KG1a.

DreamFect™ Stem has main advantages in comparison to standard procedures:

1. High transfection efficiency for multipotent Stem cells.

2. Minimized toxicity due to reagent biodegradability and low DNA amount required.

3. Cell phenotype and differentiation potential are not affected.
Human mesenchymal stem cells transfected with DreamFectTM Stem retain their potential to differentiate into osteoblasts when cultured in osteogenic differentiation medium.

4. Serum Compatible.
It has been shown that working in serum-free medium may lead to spontaneous cell differentiation of various stem cells and to heterogeneity within the treated cell population. DreamFect™ Stem allows you to work in complete medium and to avoid this kind of disagreement.

5. Simple, Ready-to-use and rapid (no specific buffer):

- Mix 3μL of DreamFectTM Stem Transfection reagent per μg of DNA (no specific dilution buffer needed)

- Incubate 20 min at room temperature

- Add the complexes to your cell growing in complete medium


DreamFect™ Stem transfection reagent is provided with a comprehensive protocol that contains all information for your Stem Cell transfection.






About OZ BIOSCIENCES

OZ Biosciences creates, develops and produces innovative tools based on drug delivery systems for th   More..e worldwide scientific community and pharmaceutical industry. OZ Biosciences focuses on technologies for the delivery of bioactive materials into living organisms.Less..

Contact Information

OZ BIOSCIENCES
Olivier ZELPHATI
163 AVENUE DE LUMINY ZONE ENTREPRISE
CASE 922 - MARSEILLE CEDEX 09
13288
Phone : 33 486 84 85 16

Tags:

stem cell research   Stem Cell Transfection Reagent   Efficiency Transfection  

Published in:

Science and Research

Published On:

February 21, 2013

Print Release:

Print Release

If you have questions regarding information in this press release contact the company listed above. I-Newswire.com is a press release service and not the author of this press release.The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies and PR Agencies submit their press releases once per week,month or quarter, make sure to check the official company website for accurate release dates as our site displays the I-Newswire.com press release distribution date only.We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for or omissions in that information or for actions taken in reliance on that information.


Related Releases

Scope Partners with AAPA to Provide “Big Data” Services
Scope e-Knowledge Center (Scope) has announced a partnership with the American Academy of Physician Assistants (AAPA), the US national professional society for physician assistants, to provide big data analytics solutions. Under the deal, Scope’s .

Russian Far Eastern Federal University Team to Participate in International Underwater Robotics Competition
The team from Russian city Vladivostok will take part in Marine Advanced Technology Education (MATE) Center's 12th Annual International Student ROV Competition, which will be held in USA (Tacoma, Washington) from 20-22 June.

Aqua Feed Market Worth $106 Billion By 2018
Aqua Feed Market was estimated to be worth around $55,685 million in 2012 and is expected to reach $106,695.7 million by 2018, growing at the CAGR of 12.1% from 2013 to 2018.

F1000Research Joins OASPA and COPE, and Is Listed in DOAJ and SHERPA/RoMEO
F1000Research is delighted to announce the journal's membership of the Open Access Scholarly Publishers Association (OASPA) and the Committee on Publication Ethics (COPE), and its listing in the Directory of Open Access Journals (DOAJ) and the SHERPA

Opening Asia Based International Open Access Journal of Science, Science Postprint, on June 11th.
Upon commencement, recruiting referees for peer-review. Part of the profit will be contributed as research funds to research institutions.